Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.
DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.
Gliapharm is a biotech startup based in Geneva, Switzerland, dedicated to reimagining brain health by focusing on the role of glial cells in brain function and health. Their team of experts is leveraging decades of research to develop new drugs targeting glia-mediated pathways for neuroprotection and cognitive function maintenance in patients with challenging neurological and psychiatric disorders. By stimulating energy utilization in the brain through astrocytes, Gliapharm aims to address brain hypometabolism, a core feature of various neurological conditions.
Mahsa Shoaran, Uisub Shin, Mohammad Ali Shaeri
Maria del Carmen Sandi Perez, Dogukan Hazar Ülgen
Henning Paul-Julius Stahlberg, Marta Di Fabrizio, Amanda Jennifer Lewis, Domenic Burger